Paper Information

Journal:   HEPATITIS MONTHLY   JUNE 2016 , Volume 16 , Number 6; Page(s) 0 To 0.
 
Paper: 

REPORTING QUALITY ASSESSMENT OF RANDOMIZED CONTROLLED TRIALS PUBLISHED IN HEPATITIS MONTHLY (LETTER)

 
 
Author(s):  KARAMBAKHSH ALIREZA, MEHRAZMAY ALIREZA, SALESI MAHMOOD*
 
* RESEARCH CENTER FOR PREVENTION OF ORAL AND DENTAL DISEASES, BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES, TEHRAN, IR IRAN
 
Abstract: 

Dear Editor: It is important that randomized clinical trials (RCTs), as the most valuable research method for assessing the efficacy of treatments, are reported with the highest possible level of quality. To evaluate the quality of published RCTs reported in Hepatitis monthly, we examined whether there was a change in the quality of reporting over time. Of the 610 articles published from 2010 to 2014, 583 nontrial or non-human trials were screened, and 27 trials were identified. Within these 27 trials, ten reports were without a control group and failed to meet our eligibility criteria. Therefore, 17 RCTs were identified. We completed a comprehensive quality assessment of each report using the short form of the CONSORT 2010 checklist (www.consortstatement. org) and a five-point quality assessment instrument called the Jadad scale.

 
Keyword(s): QUALITY ASSESSMENT, RANDOMIZED CONTROLLED TRIAL, CHECKLIST
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 59
 
Latest on Blog
Enter SID Blog